MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.
Understanding the underlying molecular mechanisms of defined cancers is crucial for effective personalized therapies. Translocations of the mixed-lineage leukemia (MLL) gene produce fusion proteins such as MLL-AF4 that disrupt epigenetic pathways and cause poor-prognosis leukemias. Here, we find tha...
Hlavní autoři: | Kerry, J, Godfrey, L, Repapi, E, Tapia, M, Blackledge, N, Ma, H, Ballabio, E, O'Byrne, S, Ponthan, F, Heidenreich, O, Roy, A, Roberts, I, Konopleva, M, Klose, R, Geng, H, Milne, T |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Cell Press
2017
|
Podobné jednotky
-
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia
Autor: Jon Kerry, a další
Vydáno: (2017-01-01) -
MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.
Autor: Godfrey, L, a další
Vydáno: (2016) -
The role of DOT1L in MLL-AF4 leukaemia
Autor: Godfrey, L
Vydáno: (2018) -
Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.
Autor: Ballabio, E, a další
Vydáno: (2012) -
P314: THERAPEUTICALLY TARGETING THE UNIQUE BARCODE OF MLL/AF4
Autor: R. Cameron, a další
Vydáno: (2022-06-01)